XML 44 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock Option Assumptions
The following weighted average assumptions were used to determine the fair value of the stock options granted on the original grant date for expense recognition purposes for options granted during the three months ended March 31, 2018 and 2017 using a Black Scholes Model:
 
 
Three months ended
 
March 31, 2018
 
March 31, 2017
Directors and Officers:
 
 
 
Expected dividend rate
$
0.26

 
$
0.26

Expected volatility
29.73
%
 
30.81
%
Risk-free interest rate
2.20
%
 
1.90
%
Expected life (in years)
5.0

 
5.0

 
 
 
 
Employees:
 

 
 

Expected dividend rate
$
0.26

 
$
0.26

Expected volatility
29.82
%
 
30.86
%
Risk-free interest rate
2.48
%
 
1.91
%
Expected life (in years)
5.0

 
5.0

Summary of Stock Options Outstanding
The following is a summary of stock options vested and exercisable as of March 31, 2018:
 
Range of
Exercise
Prices
 
Number
of
Shares
 
Weighted
Average
Remaining
Contractual Life
(in years)
 
Weighted
Average
Exercise
Price
 
Intrinsic
Value
(in thousands)
$4.54 - $32.80
 
486,601

 
5.19
 
$
16.32

 
$
11,036

$32.85 - $34.10
 
65,054

 
5.64
 
34.06

 
322

$34.15 - $39.00
 
9,193

 
8.90
 
34.45

 
42

Total
 
560,848

 
5.30
 
$
18.67

 
$
11,400

 
The following is a summary of stock options vested and exercisable as of March 31, 2017:

Range of
Exercise
Prices
 
Number
of
Shares
 
Weighted
Average
Remaining
Contractual Life
(in years)
 
Weighted
Average
Exercise
Price
 
Intrinsic
Value
(in thousands)
$4.54 - $22.76
 
341,654

 
5.41

 
$
11.31

 
$
8,213

$23.57 - $32.80
 
18,002

 
7.52

 
24.19

 
201

$32.85 - $36.70
 

 

 

 

Total
 
359,656

 
5.52

 
$
11.96

 
$
8,414

Summary of Stock Option Activity
A summary of option activity under the plans is as follows:

 
Shares
 
Weighted
Average
Exercise
Price
Outstanding at December 31, 2017
1,567,109

 
$
25.27

Granted
1,432,720

 
34.51

Exercised
(79,081
)
 
16.93

Forfeited or Expired
(99,150
)
 
33.84

Outstanding at March 31, 2018
2,821,598

 
$
29.91

Exercisable at March 31, 2018
560,848

 
$
18.67

Summary of Unvested Restricted Stock Awards
A summary of the unvested restricted stock awards is as follows:
 
 
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested at December 31, 2017
341,800

 
$
25.52

Granted
61,190

 
34.55

Vested
(47,168
)
 
23.99

Forfeited
(29,489
)
 
28.20

Unvested at March 31, 2018
326,333

 
$
27.20

Summary of Grant Date Fair Value of Awards During Period
A summary of share-based compensation is as follows:
 
 
Three months ended
 
March 31,
2018
 
March 31,
2017
Grant date fair value of awards during the period:
(in thousands)
Options
$
12,527

 
$
2,874

Restricted stock
2,114

 
2,600

Total
$
14,641

 
$
5,474

Summary of Share-Based Compensation Expense
Share-based compensation expense:
 
 
 
Options
$
758

 
$
727

Restricted stock
966

 
918

Total
$
1,724

 
$
1,645

Summary of Income Tax Benefit Related to Share-Based Compensation
Income tax benefit/(deficiency) related to share-based compensation:
 
 
 
Options
$
301

 
$
791

Restricted stock
162

 
273

Total
$
463

 
$
1,064